Intellectual property policy in the pharmaceutical sciences: the effect of inappropriate patents and market exclusivity extensions on the health care system.
about
Rising health care costs and life-cycle management in the pharmaceutical marketFixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient PharmaceuticalsImproving regulatory capacity to manage risks associated with trade agreements.Patent life of antiretroviral drugs approved in the US from 1987 to 2007.Molecular farming, patents and access to medicines.10 years after implementation of TRIPS obligations in India.
P2860
Intellectual property policy in the pharmaceutical sciences: the effect of inappropriate patents and market exclusivity extensions on the health care system.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Intellectual property policy i ...... ons on the health care system.
@en
type
label
Intellectual property policy i ...... ons on the health care system.
@en
prefLabel
Intellectual property policy i ...... ons on the health care system.
@en
P2860
P356
P1433
P1476
Intellectual property policy i ...... ons on the health care system.
@en
P2093
Aaron S Kesselheim
P2860
P2888
P304
P356
10.1208/AAPSJ0903033
P407
P577
2007-08-03T00:00:00Z
P5875
P6179
1051350270